You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盟科藥業(688373.SH):網上路演時間爲7月26日9:00-12:00
格隆匯 07-24 16:07

格隆匯7月24日丨盟科藥業(688373.SH)公告,上海盟科藥業股份有限公司(以下簡稱“發行人”或“公司”)首次公開發行人民幣普通股(A股)並在科創板上市(以下簡稱“本次發行”)的申請已於2022年3月25日經上海證券交易所科創板股票上市委員會委員審議通過,並已於2022年7月5日經中國證券監督管理委員會同意註冊(證監許可〔2022〕1204號)。

發行人和保薦機構(主承銷商)將通過網下初步詢價直接確定發行價格,網下不再進行累計投標詢價。本次初始公開發行股票數量爲130,000,000股,佔發行後發行人總股本的19.84%,全部爲公開發行新股,公司股東不進行公開發售股份。

本次發行初始戰略配售發行數量爲6,500,000股,佔發行數量的5.00%,最終戰略配售數量與初始戰略配售數量的差額將首先回撥至網下發行。回撥機制啓動前,網下初始發行數量爲98,800,000股,佔扣除初始戰略配售數量後發行數量的80.00%;回撥機制啓動前,網上初始發行數量24,700,000股,佔扣除初始戰略配售數量後發行數量的20.00%。

網上路演時間:2022年7月26日(T-1日)9:00-12:00。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account